| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |